Search

Your search keyword '"Konstantin V. Protasov"' showing total 7 results
Start Over Author "Konstantin V. Protasov"
7 results on '"Konstantin V. Protasov"'

1. IRKUTSK CARDIOLOGY SCHOOLS: HISTORY AND MODERNITY

Author

Konstantin V. Protasov

Subjects
cardiology, scientific school, irkutsk, k.r. sedov, a.a. dzizinsky, irkutsk state medical university, irkutsk state medical academy of postgraduate education., Medicine (General), R5-920
Abstract

The article is devoted to the history of the Irkutsk scientific cardiological schools formation and development, the founders of which were Academician of the Russian Academy of Medical Sciences K.R. Sedov and Corresponding Member of the Russian Academy of Sciences A.A. Dzizinsky. The biography of K.R. Sedov and A.A. Dzizinsky is presented. Their invaluable contribution to the organization and development of Irkutsk regional cardiology service, as well as cardiologists training is reflected. Particular attention is paid to the role of these outstanding scientists in the development of cardiology as a fundamental and clinical science. The modern achievements and development paths of the Irkutsk cardiological school are described. Data is provided about its current representatives – students and followers of K.R. Sedov and A.A. Dzizinsky

Published
2024
Full Text
View/download PDF

2. ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis

Author

Gregory P. Arutyunov, Ekaterina I. Tarlovskaya, Alexander G. Arutyunov, Yuri N. Belenkov, Alexandra O. Konradi, Yury M. Lopatin, Andrey P. Rebrov, Sergey N. Tereshchenko, Anna I. Chesnikova, Hamlet G. Hayrapetyan, Aleksandr P. Babin, Igor G. Bakulin, Natalia V. Bakulina, Larisa A. Balykova, Anna S. Blagonravova, Marina V. Boldina, Alexandra R. Vaisberg, Albert S. Galyavich, Veronika V. Gomonova, Natalia Yu. Grigorieva, Irina V. Gubareva, Irina V. Demko, Angelika V. Evzerikhina, Aleksandr V. Zharkov, Umida K. Kamilova, Zulfia F. Kim, Tatiana Yu. Kuznetsova, Natalia V. Lareva, Ekaterina V. Makarova, Svetlana V. Malchikova, Sergey V. Nedogoda, Marina M. Petrova, Ilya G. Pochinka, Konstantin V. Protasov, Denis N. Protsenko, Dmitry Yu. Ruzanau, Sergey A. Sayganov, Akpay S. Sarybaev, Natalia M. Selezneva, Akhmetzhan B. Sugraliev, Igor V. Fomin, Olga V. Khlynova, Olga Yu. Chizhova, Igor I. Shaposhnik, Dmitry A. Sh'ukarev, Айгуль K. Abdrahmanova, Susanna A. Avetisian, Hovhannes G. Avoyan, Karine K. Azarian, Galiya T. Aimakhanova, Dinara A. Ayipova, Almazbek Ch. Akunov, Marianna K. Alieva, Aliona V. Aparkina, Olga R. Aruslanova, Ekaterina Yu. Ashina, Olga Yu. Badina, Olga Yu. Barisheva, Alina S. Batchayeva, Anna M. Bitieva, Ismail U. Bikhteyev, Nataliya A. Borodulina, Maksim V. Bragin, Angela M. Budu, Galina M. Bykova, Kristina R. Vagapova, Darina D. Varlamova, Natalia N. Vezikova, Elena A. Verbitskaya, Olga E. Vilkova, Elena A. Vinnikova, Vera V. Vustina, Elena A. Galova, Vadim V. Genkel, Elena I. Gorshenina, Roman V. Gostishev, Elena V. Grigorieva, Ekaterina Yu. Gubareva, Gaukhar M. Dabylova, Anastasiya I. Demchenko, Oleg Yu. Dolgikh, Melis Y. Duyshobayev, Dmitrii S. Evdokimov, Ksenia E. Egorova, Anastasiia N. Ermilova, Aliya E. Zheldybayeva, Nataliya V. Zarechnova, Yuliia D. Zimina, Svetlana Yu. Ivanova, Elena Yu. Ivanchenko, Mariya V. Ilina, Maria V. Kazakovtseva, Elena V. Kazymova, Yuliya S. Kalinina, Nadezhda A. Kamardina, Anastasiya M. Karachenova, Igor A. Karetnikov, Nina A. Karoli, Magomed Kh. Karsiev, Daria S. Кaskaeva, Karina F. Kasymova, Zhainagul B. Kerimbekova, Ailar Sh. Kerimova, Eugeni S. Kim, Nina V. Kiseleva, Darya A. Klimenko, Anastasiia V. Klimova, Olga V. Kovalishena, Elena V. Kolmakova, Tatyana P. Kolchinskaya, Maria I. Kolyadich, Olga V. Kondriakova, Marina P. Konoval, Dmitryi Yu. Konstantinov, Elena A. Konstantinova, Vera A. Kordukova, Ekaterina V. Koroleva, Angelina Yu. Kraposhina, Tamara V. Kriukova, Alla S. Kuznetsova, Tatyana Yu. Kuzmina, Kirill V. Kuzmichev, Cholpon K. Kulchoroevna, Tatiana V. Kuprina, Irina M. Kouranova, Liliya V. Kurenkova, Natalia Yu. Kurchugina, Nadira A. Kushubakova, Valeriia I. Levankova, Natalia A. Lyubavina, Nadezhda A. Magdeyeva, Konstantin V. Mazalov, Viktoryia I. Majseenko, Aleksandra S. Makarova, Abdirashit M. Maripov, Anastasiia A. Marusina, Evgenii S. Melnikov, Nikita B. Moiseenko, Fazliniso N. Muradova, Rimma G. Muradyan, Shahane N. Musaelian, Anton O. Myshak, Ekaterina S. Nekaeva, Nataliia M. Nikitina, Bela B. Ogurlieva, Alla A. Odegova, Yuliia V. Omarova, Nazgul A. Omurzakova, Shynar O. Ospanova, Ekaterina V. Pahomova, Liviu D. Petrov, Svetlana S. Plastinina, Vera A. Pogrebetskaya, Dmitry S. Polyakov, Ekaterina V. Ponomarenko, Larisa L. Popova, Natalya A. Prokofeva, Inna A. Pudova, Nikita A. Rakov, Abdurakhmon N. Rahimov, Nadezhda A. Rozanova, Saltanat Serikbolkyzy, Andrei A Simonov, Valeriya V. Skachkova, Daria V. Soloveva, Irina A. Soloveva, Alexander K. Subbotin, Irina M. Sukhomlinova, Anastasiia G. Sushilova, Dilnoza R. Tagayeva, Yuliia V. Titojkina, Elena P. Tikhonova, Danil S. Tokmin, Anastasiia A. Tolmacheva, Mariya S. Torgunakova, Ksenia V. Trenogina, Natalia A. Trostianetckaia, Dmitriy A. Trofimov, Alexander A. Tulichev, Assiya T. Tursunova, Nina D. Ulanova, Oleg V. Fatenkov, Olga V. Fedorishina, Tatiana S. Fil, Irina Yu. Fomina, Irina S. Fominova, Irina A. Frolova, Svetlana M. Tsvinger, Vera V. Tsoma, Meerim B. Cholponbaeva, Tatiana I. Chudinovskikh, Olga A. Shevchenko, Tatyana V. Sheshina, Ekaterina A. Shishkina, Konstantin Yu. Shishkov, Stanislav Yu. Sherbakov, and Ekaterina A. Yausheva

Subjects
covid-19, activ registry, cardiovascular diseases, diabetes mellitus, polymorbidity, disease combinations, Medicine
Abstract

Aim. Study the impact of various combinations of comorbid original diseases in patients infected with COVID-19 later on the disease progression and outcomes of the new coronavirus infection. Materials and methods. The ACTIV registry was created on the Eurasian Association of Therapists initiative. 5,808 patients have been included in the registry: men and women with COVID-19 treated at hospital or at home. ClinicalTrials.gov ID NCT04492384. Results. Most patients with COVID-19 have original comorbid diseases (oCDs). Polymorbidity assessed by way of simple counting of oCDs is an independent factor in negative outcomes of COVID-19. Search for most frequent combinations of 2, 3 and 4 oCDs has revealed absolute domination of cardiovascular diseases (all possible variants). The most unfavorable combination of 2 oCDs includes atrial hypertension (AH) and chronic heart failure (CHF). The most unfavorable combination of 3 oCDs includes AH, coronary heart disease (CHD) and CHF; the worst combination of 4 oCDs includes AH, CHD, CHF and diabetes mellitus. Such combinations increased the risk of lethal outcomes 3.963, 4.082 and 4.215 times respectively. Conclusion. Polymorbidity determined by way of simple counting of diseases may be estimated as a factor in the lethal outcome risk in the acute phase of COVID-19 in real practice. Most frequent combinations of 2, 3 and 4 diseases in patients with COVID-19 primarily include cardiovascular diseases (AH, CHD and CHF), diabetes mellitus and obesity. Combinations of such diseases increase the COVID-19 lethal outcome risk.

Published
2022
Full Text
View/download PDF

4. The Frequency of the Minor Polymorphisms in the CYP2C19, VEGFR-2 Genes, and Clinical Outcomes in Russian and Buryat Patients with Acute Coronary Syndrome

Author

Dmitry A. Sychev, K. A. Apartsin, Konstantin Yu Nikolaev, Elena M Zelenskaya, Oyuna S Donirova, G. I. Lifshits, Elena N. Voronina, Vadim D Altayev, and Konstantin V Protasov

Subjects
0301 basic medicine, Acute coronary syndrome, biology, business.industry, VEGF receptors, Coronary stenting, Locus (genetics), General Medicine, CYP2C19, medicine.disease, Bioinformatics, Clopidogrel, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, biology.protein, Medicine, business, Gene, Genetics (clinical), medicine.drug
Abstract

Aim: To determine the differences in the frequencies of polymorphic variants at the rs4244285(*2), rs4986893 (*3), rs12248560 (*17), loci of the CYP2C19 gene, and the rs2305948 locus of the VEGFR-2...

Published
2020
Full Text
View/download PDF

5. [ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]

Author

Gregory P. Arutyunov, Ekaterina I. Tarlovskaya, Alexander G. Arutyunov, Yuri N. Belenkov, Alexandra O. Konradi, Yury M. Lopatin, Andrey P. Rebrov, Sergey N. Tereshchenko, Anna I. Chesnikova, Hamlet G. Hayrapetyan, Aleksandr P. Babin, Igor G. Bakulin, Natalia V. Bakulina, Larisa A. Balykova, Anna S. Blagonravova, Marina V. Boldina, Alexandra R. Vaisberg, Albert S. Galyavich, Veronika V. Gomonova, Natalia Yu. Grigorieva, Irina V. Gubareva, Irina V. Demko, Angelika V. Evzerikhina, Aleksandr V. Zharkov, Umida K. Kamilova, Zulfia F. Kim, Tatiana Yu. Kuznetsova, Natalia V. Lareva, Ekaterina V. Makarova, Svetlana V. Malchikova, Sergey V. Nedogoda, Marina M. Petrova, Ilya G. Pochinka, Konstantin V. Protasov, Denis N. Protsenko, Dmitry Yu. Ruzanau, Sergey A. Sayganov, Akpay S. Sarybaev, Natalia M. Selezneva, Akhmetzhan B. Sugraliev, Igor V. Fomin, Olga V. Khlynova, Olga Yu. Chizhova, Igor I. Shaposhnik, Dmitry A. Sh'ukarev, Айгуль K. Abdrahmanova, Susanna A. Avetisian, Hovhannes G. Avoyan, Karine K. Azarian, Galiya T. Aimakhanova, Dinara A. Ayipova, Almazbek Ch. Akunov, Marianna K. Alieva, Aliona V. Aparkina, Olga R. Aruslanova, Ekaterina Yu. Ashina, Olga Yu. Badina, Olga Yu. Barisheva, Alina S. Batchayeva, Anna M. Bitieva, Ismail U. Bikhteyev, Nataliya A. Borodulina, Maksim V. Bragin, Angela M. Budu, Galina M. Bykova, Kristina R. Vagapova, Darina D. Varlamova, Natalia N. Vezikova, Elena A. Verbitskaya, Olga E. Vilkova, Elena A. Vinnikova, Vera V. Vustina, Elena A. Galova, Vadim V. Genkel, Elena I. Gorshenina, Roman V. Gostishev, Elena V. Grigorieva, Ekaterina Yu. Gubareva, Gaukhar M. Dabylova, Anastasiya I. Demchenko, Oleg Yu. Dolgikh, Melis Y. Duyshobayev, Dmitrii S. Evdokimov, Ksenia E. Egorova, Anastasiia N. Ermilova, Aliya E. Zheldybayeva, Nataliya V. Zarechnova, Yuliia D. Zimina, Svetlana Yu. Ivanova, Elena Yu. Ivanchenko, Mariya V. Ilina, Maria V. Kazakovtseva, Elena V. Kazymova, Yuliya S. Kalinina, Nadezhda A. Kamardina, Anastasiya M. Karachenova, Igor A. Karetnikov, Nina A. Karoli, Magomed Kh. Karsiev, Daria S. Кaskaeva, Karina F. Kasymova, Zhainagul B. Kerimbekova, Ailar Sh. Kerimova, Eugeni S. Kim, Nina V. Kiseleva, Darya A. Klimenko, Anastasiia V. Klimova, Olga V. Kovalishena, Elena V. Kolmakova, Tatyana P. Kolchinskaya, Maria I. Kolyadich, Olga V. Kondriakova, Marina P. Konoval, Dmitryi Yu. Konstantinov, Elena A. Konstantinova, Vera A. Kordukova, Ekaterina V. Koroleva, Angelina Yu. Kraposhina, Tamara V. Kriukova, Alla S. Kuznetsova, Tatyana Yu. Kuzmina, Kirill V. Kuzmichev, Cholpon K. Kulchoroevna, Tatiana V. Kuprina, Irina M. Kouranova, Liliya V. Kurenkova, Natalia Yu. Kurchugina, Nadira A. Kushubakova, Valeriia I. Levankova, Natalia A. Lyubavina, Nadezhda A. Magdeyeva, Konstantin V. Mazalov, Viktoryia I. Majseenko, Aleksandra S. Makarova, Abdirashit M. Maripov, Anastasiia A. Marusina, Evgenii S. Melnikov, Nikita B. Moiseenko, Fazliniso N. Muradova, Rimma G. Muradyan, Shahane N. Musaelian, Anton O. Myshak, Ekaterina S. Nekaeva, Nataliia M. Nikitina, Bela B. Ogurlieva, Alla A. Odegova, Yuliia V. Omarova, Nazgul A. Omurzakova, Shynar O. Ospanova, Ekaterina V. Pahomova, Liviu D. Petrov, Svetlana S. Plastinina, Vera A. Pogrebetskaya, Dmitry S. Polyakov, Ekaterina V. Ponomarenko, Larisa L. Popova, Natalya A. Prokofeva, Inna A. Pudova, Nikita A. Rakov, Abdurakhmon N. Rahimov, Nadezhda A. Rozanova, Saltanat Serikbolkyzy, Andrei A Simonov, Valeriya V. Skachkova, Daria V. Soloveva, Irina A. Soloveva, Alexander K. Subbotin, Irina M. Sukhomlinova, Anastasiia G. Sushilova, Dilnoza R. Tagayeva, Yuliia V. Titojkina, Elena P. Tikhonova, Danil S. Tokmin, Anastasiia A. Tolmacheva, Mariya S. Torgunakova, Ksenia V. Trenogina, Natalia A. Trostianetckaia, Dmitriy A. Trofimov, Alexander A. Tulichev, Assiya T. Tursunova, Nina D. Ulanova, Oleg V. Fatenkov, Olga V. Fedorishina, Tatiana S. Fil, Irina Yu. Fomina, Irina S. Fominova, Irina A. Frolova, Svetlana M. Tsvinger, Vera V. Tsoma, Meerim B. Cholponbaeva, Tatiana I. Chudinovskikh, Olga A. Shevchenko, Tatyana V. Sheshina, Ekaterina A. Shishkina, Konstantin Yu. Shishkov, Stanislav Yu. Sherbakov, and Ekaterina A. Yausheva

Subjects
Adult, Male, Heart Failure, History, SARS-CoV-2, Endocrinology, Diabetes and Metabolism, COVID-19, Coronary Disease, General Medicine, Prognosis, Cardiovascular Diseases, Chronic Disease, Hypertension, Diabetes Mellitus, Humans, Female, Registries, Family Practice, Noncommunicable Diseases
Abstract

Study the impact of various combinations of comorbid original diseases in patients infected with COVID-19 later on the disease progression and outcomes of the new coronavirus infection.The ACTIV registry was created on the Eurasian Association of Therapists initiative. 5,808 patients have been included in the registry: men and women with COVID-19 treated at hospital or at home.gov ID NCT04492384.Most patients with COVID-19 have original comorbid diseases (oCDs). Polymorbidity assessed by way of simple counting of oCDs is an independent factor in negative outcomes of COVID-19. Search for most frequent combinations of 2, 3 and 4 oCDs has revealed absolute domination of cardiovascular diseases (all possible variants). The most unfavorable combination of 2 oCDs includes atrial hypertension (AH) and chronic heart failure (CHF). The most unfavorable combination of 3 oCDs includes AH, coronary heart disease (CHD) and CHF; the worst combination of 4 oCDs includes AH, CHD, CHF and diabetes mellitus. Such combinations increased the risk of lethal outcomes 3.963, 4.082 and 4.215 times respectively.Polymorbidity determined by way of simple counting of diseases may be estimated as a factor in the lethal outcome risk in the acute phase of COVID-19 in real practice. Most frequent combinations of 2, 3 and 4 diseases in patients with COVID-19 primarily include cardiovascular diseases (AH, CHD and CHF), diabetes mellitus and obesity. Combinations of such diseases increase the COVID-19 lethal outcome risk.Цель. Изучить влияние различных комбинаций сопутствующих заболеваний, существовавших у пациентов исходно, до инфицирования вирусом SARS-CoV-2, на тяжесть течения и исходы новой коронавирусной инфекции. Материалы и методы. Регистр АКТИВ создан по инициативе Евразийской ассоциации терапевтов. В регистр включены 5808 пациентов: мужчины и женщины с диагнозом COVID-19, находящиеся на лечении в стационаре или получающие лечение на дому. Регистрация регистра: идентификатор ClinicalTrials.gov: NCT04492384. Результаты. Подавляющее большинство пациентов с COVID-19 имеют исходные сопутствующие заболевания (иСЗ). Полиморбидность, оцененная методом простого подсчета иСЗ, является самостоятельным фактором негативного прогноза больных COVID-19. Поиск наиболее часто встречающихся комбинаций из 2, 3, 4 и более СЗ выявил абсолютное доминирование сердечно-сосудистых заболеваний во всех возможных вариантах. Наиболее неблагоприятной при сочетании 2 иСЗ была комбинация, включающая артериальную гипертензию (АГ) и хроническую сердечную недостаточность (ХСН), при сочетании 3 иСЗ комбинация, включающая АГ, ишемическую болезнь сердца (ИБС), ХСН, и при сочетании 4 иСЗ комбинация, включающая АГ, ИБС, ХСН и сахарный диабет. Наличие таких комбинаций приводило к росту риска летального исхода в 3,963, 4,082, 4,215 раза соответственно. Заключение. Полиморбидность, определенная методом простого подсчета заболеваний, может использоваться в реальной практике как фактор риска летальности в остром периоде COVID-19. В состав наиболее часто встречающихся комбинаций из 2, 3, 4 заболеваний у пациентов с COVID-19 входят преимущественно сердечно-сосудистые заболевания (АГ, ИБС, ХСН), сахарный диабет и ожирение. Комбинации этих заболеваний повышают риск летального исхода при COVID-19.

Published
2021

6. The Frequency of the Minor Polymorphisms in the

Author

Elena M, Zelenskaya, Galina I, Lifshits, Konstantin Yu, Nikolaev, Oyuna S, Donirova, Vadim D, Altayev, Konstantin A, Apartsin, Elena N, Voronina, Konstantin V, Protasov, and Dmitry A, Sychev

Subjects
Male, Ticlopidine, Genotype, Middle Aged, Polymorphism, Single Nucleotide, Vascular Endothelial Growth Factor Receptor-2, Clopidogrel, Russia, Cytochrome P-450 CYP2C19, Siberia, Asian People, Gene Frequency, Ethnicity, Humans, Female, Acute Coronary Syndrome, Alleles, Platelet Aggregation Inhibitors, Aged
Published
2020

7. 2214-PUB: Cytokine Profile in Patients with Type 2 Diabetes Mellitus and Evolution of ST-Elevation Acute Myocardial Infarction of Buryat Ethnic Group

Author

Konstantin V Protasov, Tatiana Bardymova, Maksim Mistiakov, Tatiana Belochvostikova, Marina Berezina, Oyuna S Donirova, and Seseg Tsyretorova

Subjects
medicine.medical_specialty, endocrine system diseases, business.industry, Endocrinology, Diabetes and Metabolism, ST elevation, Cytokine profile, Ethnic group, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, medicine.disease, surgical procedures, operative, Internal medicine, Internal Medicine, medicine, In patient, cardiovascular diseases, Myocardial infarction, business
Abstract

Inflammatory processes during type 2 diabetes mellitus (T2D) and evolution of ST-elevation acute myocardial infarction (STEMI) are different in various ethnic groups. Buryats are the main northern group of Mongolians, they are a core population of Siberia. We have examined the associations between cytokines and high sensitivity C-reactive protein (hs-CRP) in 14 patients (36% males) with T2D and STEMI of Buryat ethnic group (60 years, diabetes duration 7.9 years, A1c 8.0%); in 21 Caucasian patients (48% males) with T2D and STEMI (60 years, diabetes duration 8.0 years, A1c 7.9%); in 13 patients (77% males, 59 years) with STEMI without T2D of Buryat ethnic group and 18 Caucasian patients (72% males, 61 years) with STEMI without T2D.Buryat patients with T2D and STEMI had higher hs-CRP and lower interleukin-8 (IL-8) and interleukin-10 (IL-10) compared to Buryat patients with STEMI without T2D. Caucasian patients with T2D and STEMI had higher hs-CRP and lower tumor necrosis factor alpha (TNF-α) compared to Caucasian patients with STEMI without T2D. Buryat patients with T2D and STEMI had lower interleukin-6 (IL-6), IL-8, IL-10 and hs-CRP compared to Caucasian patients with T2D and STEMI. We have determined decreased secretion of cytokines and hs-CRP in patients with T2D and STEMI of Buryat ethnic group compared to Caucasian patients. Disclosure T. Bardymova: None. K. Protasov: None. T. Belochvostikova: None. S. Tsyretorova: None. M. Mistiakov: None. O. Donirova: None. M. Berezina: None.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results